Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
mHealth is a common term for the use of mobile phones and other wireless technology in medical care. The most general application of mHealth is the use of mobile devices to educate clients about preventive healthcare services. However, mHealth is also used for disease investigation, epidemic outbreak tracking, treatment support and chronic disease management. Furthermore, mHealth is becoming a popular option in underserved areas where there is a large population and widespread mobile phone use. For consumers, a major benefit of mHealth is its convenience. Moreover, wearable devices and other mobile technology permit users to continuously track and accomplish certain health data without having to see their healthcare provider. In addition, digital technologies and electronic healthcare, represent a foremost opportunity to rethink various chronic diseases, as they are expected to have a major impact on all aspects of diseases, from prevention to research, including medical health care and management.
The mHealth market has gained significant growth owing to the growing occurrence of preventable chronic diseases and increasing focus on preventive healthcare. Moreover, accumulative penetration of smartphones, tablets, and other mobile platforms, growing consumption of connected devices & mHealth apps and advancements in technologies are some of the major factors contributing to the growth of this market. However, lack of awareness and low guidance from physicians in selecting apps are the factor hampering the growth of mHealth market.
The mHealth market is classified by product & services, application, end user and geography
The products & services in this report are mHealth apps, connected medical devices and mHealth services. The mhealth apps segment is classified into healthcare apps and medical apps. Among these, the healthcare apps segment is further divided into General Health & Fitness Apps, Chronic Care Management Apps, Medication Management Apps, Women’s Health Apps, Personal Health Record Apps and Other Healthcare Apps. Likewise, the medical apps is further sub segmented into medical reference apps, continuing medical education apps, patient management & monitoring apps and communication & consulting apps. Furthermore, the connected medical devices segment is categorized into clinical devices and consumer health devices. The clinical devices segment is further classified into vital signs monitoring devices, peak flowmeters, fetal monitoring devices, multiparameter trackers, sleep apnea monitors, neurological monitoring devices and other clinical devices. The vital signs monitoring devices segment is further divided into blood pressure monitors, blood glucose meters, ECG/heart rate monitors and pulse oximeters. Moreover, the mHealth services segment is categorized into remote monitoring services, diagnosis & consultation services, treatment services, healthcare system strengthening services, fitness & wellness services and prevention services.
Based on application, the mHealth market is segmented into preventive applications and treatment/care-related applications. The preventive applications segment is further bifurcated into prediabetes and obesity. Likewise, the treatment/care-related applications segment is divided into diabetes, central nervous system (CNS) disorders, chronic respiratory diseases (CRD), musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence and other applications.
Various end user studied in this report are self/home healthcare, hospitals & specialty clinics and academic & research institutes. The self/home healthcare segment is expected to account for the largest market share in 2018, due to the move toward home care & self-management of diabetes and advancement in technology.
On the basis of geography, the mHealth market is segmented into North America, Europe, Asia-Pacific and Rest of the world. North America region dominated the mHealth market in 2018 due to advancement in technology solutions, high adoption of remote online coaching services for diabetes management, the high penetration of mobile devices, the development and adoption of innovative technologies and improving consumer accessibility to connected medical devices.
Some of the major players operating in the mHealth market includes Agamatrix, Inc., Airstrip Technologies, Alivecor, Inc., Apple Inc., AT&T, Inc., Athenahealth, Inc., Cisco Systems, Inc., Ihealth Lab Inc., Johnson & Johnson, Koninklijke Philips N.V., Medtronic PLC, 2Morrow, Inc., Big Health, BiogeniQ Inc., BioTelemetry, Inc., Blue Mesa Health, Canary Health, Claritas MindSciences, Digital Therapeutics, Dthera Sciences, Firstbeat Technologies Ltd, Ginger.io, Inc., Glooko, Inc., HealthMine, Inc., Mango Health, Meru Health, Inc., Noom, Inc., Pear Therapeutics, Inc., Propeller Health, Twine Health, Inc., Virta Health Corp, Zest Health, LLC, Dexcom, Inc., FitBit, Inc., Jawbone, Livongo Health, Omada Health, Inc., Proteus Digital Health, WellDoc, Inc. and Withings. Various strategies, such as expansions, joint ventures, mergers & acquisitions and others have been applied by key manufacturers to gain stronghold of the market.
July 2017: Glooko and Novo Nordisk announced the new Cornerstones4Care Powered by Glooko app (C4C app) to help people more effectively manage their diabetes. The C4C mobile app marries Novo Nordisk's extensive knowledge of diabetes and personalized patient support with Glooko's digital platform and data analytics expertise
October 2018: Welldoc announced one of the world’s leading academic medical centers is moving into Phase 2 for ongoing Quality Improvement research of BlueStar, its FDA-cleared digital therapeutic, in the treatment of patients with type 2 diabetes within primary care
October 2018: Livongo, the consumer health pioneer empowering people with chronic conditions to live better and healthier lives, announced a new category of technologies and capabilities, Applied Health Signals, that for the first time combines data science, behavior enablement, and clinical impact to reinvent the healthcare experience for people with chronic conditions
The mHealth market is classified by product & services, application, end user and geography. The products & services in this report are mHealth Apps, connected medical devices and mHealth services. The mhealth apps segment is classified into healthcare apps and medical apps. Among these, the healthcare apps segment is further divided into General Health & Fitness Apps, Chronic Care Management Apps, Medication Management Apps, Women’s Health Apps, Personal Health Record Apps and Other Healthcare Apps. Likewise, the medical apps is further sub segmented into medical reference apps, continuing medical education apps, patient management & monitoring apps and communication & consulting apps. Furthermore, the connected medical devices segment is categorized into clinical devices and consumer health devices. The clinical devices segment is further classified into vital signs monitoring devices, peak flowmeters, fetal monitoring devices, multiparameter trackers, sleep apnea monitors, neurological monitoring devices and other clinical devices. The vital signs monitoring devices segment is further divided into blood pressure monitors, blood glucose meters, ECG/heart rate monitors and pulse oximeters. Moreover, the mHealth services segment is categorized into remote monitoring services, diagnosis & consultation services, treatment services, healthcare system strengthening services, fitness & wellness services and prevention services.
Based on application, the mHealth market is segmented into preventive applications and treatment/care-related applications. The preventive applications segment is further bifurcated into prediabetes and obesity. Likewise, the treatment/care-related applications segment is divided into diabetes, central nervous system (CNS) disorders, chronic respiratory diseases (CRD), musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence and other applications.
The various end user studied in this report are self/home healthcare, hospitals & specialty diabetes clinics and academic & research institutes. The self/home healthcare segment is expected to account for the largest market share in 2018, due to the move toward home care & self-management of diabetes and advancement in technology.
On the basis of geography, the mHealth market is segmented into North America, Europe, Asia-Pacific and Rest of the world. North America region dominated the mHealth market in 2018 due to advancement in technology solutions, high adoption of remote online coaching services for diabetes management, the high penetration of mobile devices, the development and adoption of innovative technologies and improving consumer accessibility to connected medical devices.
Why to buy this report:
